ArticleCancers2024

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Anastasia Xagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.